Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Horowitz

Showing results (491-500 of 599) with videos related to

Pageof 60
Sort By:
British Journal of Clinical Pharmacology|March 18, 2004
Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineBenjamin J L Davies, Janet K Coller, Heather M James, et al.
Herz|July 3, 2015
Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieuNathan E K Procter, Jocasta Ball, Doan T M Ngo, et al.
Journal of Cardiovascular Pharmacology|May 5, 2001
Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failureG R Ellis, R A Anderson, Y Y Chirkov, et al.
Plos One|November 13, 2012
The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophyJennifer C Irvine, Virat Ganthavee, Jane E Love, et al.
JACC. Basic to Translational Science|July 10, 2024
Thrombospondin-1 Drives Cardiac Remodeling in Chronic Kidney DiseaseSohel M Julovi, Katie Trinh, Harry Robertson, et al.
Heart and Vessels|August 29, 2019
Endothelial dysfunction and glycocalyx shedding in heart failure: insights from patients receiving cardiac resynchronisation therapyChukwudiebube N Ajaero, Nathan E K Procter, Yuliy Y Chirkov, et al.
Circulation|December 11, 1999
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study GroupM Packer, P A Poole-Wilson, P W Armstrong, et al.
Recent Progress in Hormone Research|January 1, 1988
Identification of the cis-acting elements and trans-acting factors that mediate cell-specific and thyroid hormone stimulation of growth hormone gene expressionH H Samuels, A Aranda, J Casanova, et al.
Cancer Treatment Reports|April 1, 1985
Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplantsM E Trigg, R Billing, P M Sondel, et al.
Plos One|May 11, 2017
Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adultsAnjalee T Amarasekera, Bahador Assadi-Khansari, Saifei Liu, et al.
Pageof 60

Showing results (491-500 of 599) with videos related to

Sort By:
Pageof 60
British Journal of Clinical Pharmacology|March 18, 2004
Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineBenjamin J L Davies, Janet K Coller, Heather M James, et al.
Herz|July 3, 2015
Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieuNathan E K Procter, Jocasta Ball, Doan T M Ngo, et al.
Journal of Cardiovascular Pharmacology|May 5, 2001
Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failureG R Ellis, R A Anderson, Y Y Chirkov, et al.
Plos One|November 13, 2012
The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophyJennifer C Irvine, Virat Ganthavee, Jane E Love, et al.
JACC. Basic to Translational Science|July 10, 2024
Thrombospondin-1 Drives Cardiac Remodeling in Chronic Kidney DiseaseSohel M Julovi, Katie Trinh, Harry Robertson, et al.
Heart and Vessels|August 29, 2019
Endothelial dysfunction and glycocalyx shedding in heart failure: insights from patients receiving cardiac resynchronisation therapyChukwudiebube N Ajaero, Nathan E K Procter, Yuliy Y Chirkov, et al.
Circulation|December 11, 1999
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study GroupM Packer, P A Poole-Wilson, P W Armstrong, et al.
Recent Progress in Hormone Research|January 1, 1988
Identification of the cis-acting elements and trans-acting factors that mediate cell-specific and thyroid hormone stimulation of growth hormone gene expressionH H Samuels, A Aranda, J Casanova, et al.
Cancer Treatment Reports|April 1, 1985
Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplantsM E Trigg, R Billing, P M Sondel, et al.
Plos One|May 11, 2017
Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adultsAnjalee T Amarasekera, Bahador Assadi-Khansari, Saifei Liu, et al.
Pageof 60